![]() | • レポートコード:IMA2882NE3364 • 出版社/出版日:IMARC / 2026年1月 • レポート形態:英語、PDF、約100ページ • 納品方法:Eメール(納期:3日) • 産業分類:バイオ |
| Single User(1名様閲覧用) | ¥623,844 (USD3,999) | ▷ お問い合わせ |
| Five User(5名様閲覧用) | ¥779,844 (USD4,999) | ▷ お問い合わせ |
| Corporate User(閲覧人数無制限) | ¥935,844 (USD5,999) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
| 日本の抗体市場規模は、2025年に2億5,560万米ドルに達しました。今後、IMARC Groupは、同市場が2034年までに5億1,090万米ドルに達し、2026年から2034年にかけて8.00%の年平均成長率(CAGR)を示すと予測しています。継続的な医療の進歩と、拡大するバイオテクノロジー産業が、市場成長の主な原動力となっています。 糖タンパク質である抗体は、免疫系の重要な構成要素として機能し、体液中に存在しています。抗体は血流内を循環し、ウイルスや細菌などの異物である抗原に対する防御役を果たします。抗原を特異的に認識し結合する能力を持つため、抗体は生物学研究において不可欠なツールとなっています。その結果、抗体は特定の細胞成分を同定する上で極めて重要な役割を果たしており、研究分野における日常的な診断検査の開発においても不可欠である。抗体研究には、免疫組織化学(IHC)、免疫蛍光法、ウエスタンブロッティング、フローサイトメトリー、免疫沈降法、酵素免疫測定法(ELISA)など、いくつかの一般的な技術が広く用いられている。 日本の研究用抗体市場の動向: 日本の研究用抗体市場は、ライフサイエンスおよび医学研究の分野において著しい成長と重要性を示しています。これはいくつかの主要な要因に起因しています。第一に、科学の進歩とイノベーションに対する同国の強固なコミットメントが、研究開発活動への資金提供の増加につながり、研究用抗体への需要を刺激しています。さらに、日本における活況を呈する製薬およびバイオテクノロジー産業が、創薬、開発、および診断用途における高品質な抗体の利用を牽引しています。高齢化や健康への関心の高まりを特徴とする日本の医療環境の変化は、臨床研究や診断における抗体への需要をさらに強めています。抗体は、疾患マーカーの特定や複雑な生物学的経路の解明において極めて重要な役割を果たしており、標的療法やプレシジョン・メディシン(精密医療)アプローチの開発に貢献しています。さらに、日本における個別化医療への重視や、がん研究におけるその重要性の高まりは、特定の患者プロファイルに合わせた研究用抗体への需要を後押ししています。この個別化アプローチは、治療成果の向上において計り知れない可能性を秘めています。日本の研究用抗体市場は、免疫組織化学、フローサイトメトリー、ELISA、ウェスタンブロッティングなど、幅広い用途を網羅しています。卓越した科学技術の基盤、活発化する研究活動、そして最先端の医療進歩への取り組みを背景に、この地域市場は今後数年間で急速に拡大すると予想されます。 日本の研究用抗体市場のセグメンテーション: IMARC Groupは、市場の各セグメントにおける主要なトレンドの分析に加え、2026年から2034年までの国別予測を提供しています。当社のレポートでは、市場をタイプ、技術、供給源、用途、エンドユーザーに基づいて分類しています。 タイプ別インサイト: モノクローナル抗体 ポリクローナル抗体 本レポートでは、タイプに基づく市場の詳細な内訳と分析を提供しています。これには、モノクローナル抗体およびポリクローナル抗体が含まれます。 技術別インサイト: 免疫化学 免疫蛍光法 ウエスタンブロッティング フローサイトメトリー 免疫沈降法 ELISA その他 本レポートでは、技術に基づく市場の詳細な分類と分析も提供されています。これには、免疫化学、免疫蛍光法、ウエスタンブロッティング、フローサイトメトリー、免疫沈降法、ELISA、その他が含まれます。 供給源に関する分析: マウス抗体 ウサギ抗体 ヤギ抗体 その他 本レポートでは、供給源に基づく市場の詳細な分類と分析を提供しています。これには、マウス抗体、ウサギ抗体、ヤギ抗体、その他が含まれます。 用途別インサイト: 感染症 免疫学 腫瘍学 幹細胞 神経生物学 その他 本レポートでは、用途に基づく市場の詳細な分類と分析も提供されています。これには、感染症、免疫学、腫瘍学、幹細胞、神経生物学、その他が含まれます。 エンドユーザーに関する分析: 学術・研究機関 受託研究機関 製薬・バイオテクノロジー企業 本レポートでは、エンドユーザー別の市場の詳細な分類と分析を提供しています。これには、学術・研究機関、受託研究機関、および製薬・バイオテクノロジー企業が含まれます。 競合環境: 本市場調査レポートでは、市場の競合環境に関する包括的な分析も提供しています。市場構造、主要企業のポジショニング、主要な成功戦略、競合ダッシュボード、企業評価クアドラントなどの競合分析がレポートで網羅されています。また、主要企業の詳細なプロファイルも掲載されています。 |
Japan research antibodies market size reached USD 255.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 510.9 Million by 2034, exhibiting a growth rate (CAGR) of 8.00% during 2026-2034. Continuous medical advancements, coupled with the expanding biotechnology industry, are primarily driving the market growth.
Antibodies, which are glycoproteins, serve as vital constituents of the immune system, and they are present in body fluids. They circulate within the bloodstream and serve as defenders against antigens, which are foreign substances such as viruses and bacteria. Due to their ability to specifically recognize and bind to antigens, antibodies are essential tools in biological research. Consequently, they play a pivotal role in identifying specific cellular components and are crucial in the development of routine diagnostic tests within the research domain. Several common technologies are extensively employed for antibody research, including immunohistochemistry (IHC), immunofluorescence, western blotting, flow cytometry, immunoprecipitation, and enzyme-linked immunosorbent assay (ELISA).
Japan Research Antibodies Market Trends:
The Japan research antibodies market is witnessing substantial growth and significance within the field of life sciences and medical research. This can be attributed to several key factors. Firstly, the country’s robust commitment to scientific advancement and innovation has led to increased funding for research and development activities, spurring demand for research antibodies. Additionally, Japan’s thriving pharmaceutical and biotechnology industries are driving the usage of high-quality antibodies for drug discovery, development, and diagnostic applications. The evolving healthcare landscape in Japan, marked by an aging population and increasing health concerns, has intensified the demand for antibodies in clinical research and diagnostics. Antibodies play a pivotal role in identifying disease markers and understanding complex biological pathways, contributing to the development of targeted therapies and precision medicine approaches. Furthermore, Japan’s emphasis on personalized medicine and its growing significance in cancer research are bolstering the demand for research antibodies tailored to specific patient profiles. This personalized approach holds immense potential for improving treatment outcomes. The Japan research antibodies market encompasses a wide range of applications, including immunohistochemistry, flow cytometry, ELISA, and western blotting. With a strong foundation in scientific excellence, increasing research activities, and a commitment to cutting-edge medical advancements, the regional market is expected to catalyze in the coming years.
Japan Research Antibodies Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on type, technology, source, application, and end user.
Type Insights:
• Monoclonal Antibodies
• Polyclonal Antibodies
The report has provided a detailed breakup and analysis of the market based on the type. This includes monoclonal antibodies and polyclonal antibodies.
Technology Insights:
• Immunochemistry
• Immunofluorescence
• Western Blotting
• Flow Cytometry
• Immunoprecipitation
• ELISA
• Others
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes immunochemistry, immunofluorescence, western blotting, flow cytometry, immunoprecipitation, ELISA, and others.
Source Insights:
• Mouse Antibodies
• Rabbit Antibodies
• Goat Antibodies
• Others
The report has provided a detailed breakup and analysis of the market based on the source. This includes mouse antibodies, rabbit antibodies, goat antibodies, and others.
Application Insights:
• Infectious Diseases
• Immunology
• Oncology
• Stem Cells
• Neurobiology
• Others
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes infectious diseases, immunology, oncology, stem cells, neurobiology, and others.
End User Insights:
• Academic and Research Institutes
• Contract Research Organizations
• Pharmaceutical and Biotechnology Companies
The report has provided a detailed breakup and analysis of the market based on the end user. This includes academic and research institutes, contract research organizations, and pharmaceutical and biotechnology companies.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Japan Research Antibodies Market – Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Japan Research Antibodies Market Landscape
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 Japan Research Antibodies Market – Breakup by Type
6.1 Monoclonal Antibodies
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Polyclonal Antibodies
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
7 Japan Research Antibodies Market – Breakup by Technology
7.1 Immunochemistry
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Immunofluorescence
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Western Blotting
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (2026-2034)
7.4 Flow Cytometry
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Forecast (2026-2034)
7.5 Immunoprecipitation
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2020-2025)
7.5.3 Market Forecast (2026-2034)
7.6 ELISA
7.6.1 Overview
7.6.2 Historical and Current Market Trends (2020-2025)
7.6.3 Market Forecast (2026-2034)
7.7 Others
7.7.1 Historical and Current Market Trends (2020-2025)
7.7.2 Market Forecast (2026-2034)
8 Japan Research Antibodies Market – Breakup by Source
8.1 Mouse Antibodies
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Rabbit Antibodies
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Goat Antibodies
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Others
8.4.1 Historical and Current Market Trends (2020-2025)
8.4.2 Market Forecast (2026-2034)
9 Japan Research Antibodies Market – Breakup by Application
9.1 Infectious Diseases
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Immunology
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Oncology
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Forecast (2026-2034)
9.4 Stem Cells
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2020-2025)
9.4.3 Market Forecast (2026-2034)
9.5 Neurobiology
9.5.1 Overview
9.5.2 Historical and Current Market Trends (2020-2025)
9.5.3 Market Forecast (2026-2034)
9.6 Others
9.6.1 Historical and Current Market Trends (2020-2025)
9.6.2 Market Forecast (2026-2034)
10 Japan Research Antibodies Market – Breakup by End User
10.1 Academic and Research Institutes
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Forecast (2026-2034)
10.2 Contract Research Organizations
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Forecast (2026-2034)
10.3 Pharmaceutical and Biotechnology Companies
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Forecast (2026-2034)
11 Japan Research Antibodies Market – Breakup by Region
11.1 Kanto Region
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2020-2025)
11.1.3 Market Breakup by Type
11.1.4 Market Breakup by Technology
11.1.5 Market Breakup by Source
11.1.6 Market Breakup by Application
11.1.7 Market Breakup by End User
11.1.8 Key Players
11.1.9 Market Forecast (2026-2034)
11.2 Kansai/Kinki Region
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2020-2025)
11.2.3 Market Breakup by Type
11.2.4 Market Breakup by Technology
11.2.5 Market Breakup by Source
11.2.6 Market Breakup by Application
11.2.7 Market Breakup by End User
11.2.8 Key Players
11.2.9 Market Forecast (2026-2034)
11.3 Central/ Chubu Region
11.3.1 Overview
11.3.2 Historical and Current Market Trends (2020-2025)
11.3.3 Market Breakup by Type
11.3.4 Market Breakup by Technology
11.3.5 Market Breakup by Source
11.3.6 Market Breakup by Application
11.3.7 Market Breakup by End User
11.3.8 Key Players
11.3.9 Market Forecast (2026-2034)
11.4 Kyushu-Okinawa Region
11.4.1 Overview
11.4.2 Historical and Current Market Trends (2020-2025)
11.4.3 Market Breakup by Type
11.4.4 Market Breakup by Technology
11.4.5 Market Breakup by Source
11.4.6 Market Breakup by Application
11.4.7 Market Breakup by End User
11.4.8 Key Players
11.4.9 Market Forecast (2026-2034)
11.5 Tohoku Region
11.5.1 Overview
11.5.2 Historical and Current Market Trends (2020-2025)
11.5.3 Market Breakup by Type
11.5.4 Market Breakup by Technology
11.5.5 Market Breakup by Source
11.5.6 Market Breakup by Application
11.5.7 Market Breakup by End User
11.5.8 Key Players
11.5.9 Market Forecast (2026-2034)
11.6 Chugoku Region
11.6.1 Overview
11.6.2 Historical and Current Market Trends (2020-2025)
11.6.3 Market Breakup by Type
11.6.4 Market Breakup by Technology
11.6.5 Market Breakup by Source
11.6.6 Market Breakup by Application
11.6.7 Market Breakup by End User
11.6.8 Key Players
11.6.9 Market Forecast (2026-2034)
11.7 Hokkaido Region
11.7.1 Overview
11.7.2 Historical and Current Market Trends (2020-2025)
11.7.3 Market Breakup by Type
11.7.4 Market Breakup by Technology
11.7.5 Market Breakup by Source
11.7.6 Market Breakup by Application
11.7.7 Market Breakup by End User
11.7.8 Key Players
11.7.9 Market Forecast (2026-2034)
11.8 Shikoku Region
11.8.1 Overview
11.8.2 Historical and Current Market Trends (2020-2025)
11.8.3 Market Breakup by Type
11.8.4 Market Breakup by Technology
11.8.5 Market Breakup by Source
11.8.6 Market Breakup by Application
11.8.7 Market Breakup by End User
11.8.8 Key Players
11.8.9 Market Forecast (2026-2034)
12 Japan Research Antibodies Market – Competitive Landscape
12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant
13 Profiles of Key Players
13.1 Company A
13.1.1 Business Overview
13.1.2 Product Portfolio
13.1.3 Business Strategies
13.1.4 SWOT Analysis
13.1.5 Major News and Events
13.2 Company B
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Business Strategies
13.2.4 SWOT Analysis
13.2.5 Major News and Events
13.3 Company C
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Business Strategies
13.3.4 SWOT Analysis
13.3.5 Major News and Events
13.4 Company D
13.4.1 Business Overview
13.4.2 Product Portfolio
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 Company E
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Business Strategies
13.5.4 SWOT Analysis
13.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.
14 Japan Research Antibodies Market – Industry Analysis
14.1 Drivers, Restraints, and Opportunities
14.1.1 Overview
14.1.2 Drivers
14.1.3 Restraints
14.1.4 Opportunities
14.2 Porters Five Forces Analysis
14.2.1 Overview
14.2.2 Bargaining Power of Buyers
14.2.3 Bargaining Power of Suppliers
14.2.4 Degree of Competition
14.2.5 Threat of New Entrants
14.2.6 Threat of Substitutes
14.3 Value Chain Analysis
15 Appendix
